These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24389532)

  • 21. Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.
    Herzer K; Müller S; Antoch G; Hilgard P
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):287-98. PubMed ID: 21769078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.
    Salem R; Thurston KG
    J Vasc Interv Radiol; 2006 Sep; 17(9):1425-39. PubMed ID: 16990462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction.
    Salem R; Thurston KG
    J Vasc Interv Radiol; 2006 Oct; 17(10):1571-93. PubMed ID: 17056999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outpatient single-session yttrium-90 glass microsphere radioembolization.
    Gates VL; Marshall KG; Salzig K; Williams M; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy.
    Gulec SA; Sztejnberg ML; Siegel JA; Jevremovic T; Stabin M
    J Nucl Med; 2010 Feb; 51(2):301-10. PubMed ID: 20080888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From the Food and Drug Administration.
    Crawford LM
    JAMA; 2002 May; 287(17):2203. PubMed ID: 11980508
    [No Abstract]   [Full Text] [Related]  

  • 27. Intrahepatic (90)Y-microspheres for hepatocellular carcinoma.
    Ho S; Lau JW; Leung TW
    J Nucl Med; 2001 Oct; 42(10):1587-9. PubMed ID: 11585877
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.
    Goin JE; Salem R; Carr BI; Dancey JE; Soulen MC; Geschwind JF; Goin K; Van Buskirk M; Thurston K
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):195-203. PubMed ID: 15713920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microdosimetric considerations of hepatic radioembolization.
    Feinendegen LE
    J Nucl Med; 1994 Oct; 35(10):1644-6. PubMed ID: 7931663
    [No Abstract]   [Full Text] [Related]  

  • 30. Selective internal radiation therapy: 90Y (yttrium) labeled microspheres for liver malignancies (primary and metastatic).
    Uthappa MC; Ravikumar R; Gupta A
    Indian J Cancer; 2011; 48(1):18-23. PubMed ID: 21330750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases.
    Gulec SA; Fong Y
    Arch Surg; 2007 Jul; 142(7):675-82. PubMed ID: 17638807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound guided internal radiotherapy using yttrium-90 glass microspheres for liver malignancies.
    Ho S; Lau WY; Leung WT
    J Nucl Med; 1997 Jul; 38(7):1169-70. PubMed ID: 9225814
    [No Abstract]   [Full Text] [Related]  

  • 33. Production and separation of non-carrier-added 86Y from enriched 86Sr targets.
    Avila-Rodriguez MA; Nye JA; Nickles RJ
    Appl Radiat Isot; 2008 Jan; 66(1):9-13. PubMed ID: 17869530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two new techniques to treat inoperable liver tumors.
    Oncology (Williston Park); 1991 Feb; 5(2):41. PubMed ID: 1826207
    [No Abstract]   [Full Text] [Related]  

  • 35. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
    Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432.
    Ho S; Lau WY; Leung WT
    Chin Med J (Engl); 2001 Apr; 114(4):433-4. PubMed ID: 11780473
    [No Abstract]   [Full Text] [Related]  

  • 37. Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study.
    Benson AB; Geschwind JF; Mulcahy MF; Rilling W; Siskin G; Wiseman G; Cunningham J; Houghton B; Ross M; Memon K; Andrews J; Fleming CJ; Herman J; Nimeiri H; Lewandowski RJ; Salem R
    Eur J Cancer; 2013 Oct; 49(15):3122-30. PubMed ID: 23777743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
    Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report.
    Kennedy A; Coldwell D; Sangro B; Wasan H; Salem R
    Am J Clin Oncol; 2012 Feb; 35(1):81-90. PubMed ID: 20938320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What determines survival duration in hepatocellular carcinoma treated with intraarterial Yttrium-90 microspheres?
    Lau WY; Ho S; Leung WT; Chan M; Lee WY; Johnson PJ
    Hepatogastroenterology; 2001; 48(38):338-40. PubMed ID: 11379304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.